Structure

Physi-Chem Properties

Molecular Weight:  440.37
Volume:  502.881
LogP:  6.778
LogD:  5.6
LogS:  -6.526
# Rotatable Bonds:  5
TPSA:  37.3
# H-Bond Aceptor:  2
# H-Bond Donor:  1
# Rings:  4
# Heavy Atoms:  2

MedChem Properties

QED Drug-Likeness Score:  0.449
Synthetic Accessibility Score:  4.844
Fsp3:  0.833
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.926
MDCK Permeability:  1.3644939826917835e-05
Pgp-inhibitor:  0.974
Pgp-substrate:  0.0
Human Intestinal Absorption (HIA):  0.003
20% Bioavailability (F20%):  0.924
30% Bioavailability (F30%):  0.102

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.054
Plasma Protein Binding (PPB):  93.41405487060547%
Volume Distribution (VD):  0.973
Pgp-substrate:  2.4290997982025146%

ADMET: Metabolism

CYP1A2-inhibitor:  0.069
CYP1A2-substrate:  0.645
CYP2C19-inhibitor:  0.257
CYP2C19-substrate:  0.96
CYP2C9-inhibitor:  0.394
CYP2C9-substrate:  0.126
CYP2D6-inhibitor:  0.249
CYP2D6-substrate:  0.21
CYP3A4-inhibitor:  0.904
CYP3A4-substrate:  0.905

ADMET: Excretion

Clearance (CL):  6.248
Half-life (T1/2):  0.049

ADMET: Toxicity

hERG Blockers:  0.419
Human Hepatotoxicity (H-HT):  0.147
Drug-inuced Liver Injury (DILI):  0.583
AMES Toxicity:  0.014
Rat Oral Acute Toxicity:  0.104
Maximum Recommended Daily Dose:  0.108
Skin Sensitization:  0.315
Carcinogencity:  0.203
Eye Corrosion:  0.023
Eye Irritation:  0.036
Respiratory Toxicity:  0.978

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC131470

Natural Product ID:  NPC131470
Common Name*:   3Beta-Hydroxy-4Alpha-14Alpha-Dimethyl-5Alpha-Ergosta-8-24(28)-Dien-7-One
IUPAC Name:   (3S,4S,5S,10S,13R,14R,17R)-3-hydroxy-4,10,13,14-tetramethyl-17-[(2R)-6-methyl-5-methylideneheptan-2-yl]-2,3,4,5,6,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-7-one
Synonyms:  
Standard InCHIKey:  CHJYKAZVNHSGMF-OOTSOQCUSA-N
Standard InCHI:  InChI=1S/C30H48O2/c1-18(2)19(3)9-10-20(4)22-11-16-30(8)27-23(12-15-29(22,30)7)28(6)14-13-25(31)21(5)24(28)17-26(27)32/h18,20-22,24-25,31H,3,9-17H2,1-2,4-8H3/t20-,21+,22-,24+,25+,28-,29-,30+/m1/s1
SMILES:  CC(C(=C)CC[C@H]([C@H]1CC[C@@]2([C@]1(C)CCC1=C2C(=O)C[C@@H]2[C@]1(C)CC[C@@H]([C@H]2C)O)C)C)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL479505
PubChem CID:   15478799
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000258] Steroids and steroid derivatives
        • [CHEMONTID:0003567] Ergostane steroids
          • [CHEMONTID:0001403] Ergosterols and derivatives

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO11757 Euphorbia chamaesyce Species Euphorbiaceae Eukaryota whole herb n.a. n.a. PMID[10650087]
NPO5731 Euphorbia humifusa Species Euphorbiaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO5731 Euphorbia humifusa Species Euphorbiaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO5731 Euphorbia humifusa Species Euphorbiaceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO5731 Euphorbia humifusa Species Euphorbiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO11757 Euphorbia chamaesyce Species Euphorbiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO2922 Botryosphaeria berengeriana Species Botryosphaeriaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT80 Cell Line Raji Homo sapiens Activity = 70.0 % PMID[464576]
NPT2 Others Unspecified Activity = 0.0 % PMID[464576]
NPT2 Others Unspecified Activity = 21.2 % PMID[464576]
NPT2 Others Unspecified Activity = 70.0 % PMID[464576]
NPT2 Others Unspecified Activity = 91.1 % PMID[464576]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC131470 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC143767
0.988 High Similarity NPC86319
0.988 High Similarity NPC275740
0.9762 High Similarity NPC183283
0.9756 High Similarity NPC72133
0.9647 High Similarity NPC63748
0.9535 High Similarity NPC69454
0.9524 High Similarity NPC471722
0.9524 High Similarity NPC328539
0.9425 High Similarity NPC166906
0.9318 High Similarity NPC259286
0.9318 High Similarity NPC470016
0.9318 High Similarity NPC317586
0.9302 High Similarity NPC191684
0.9294 High Similarity NPC471724
0.9277 High Similarity NPC473246
0.9213 High Similarity NPC328162
0.9213 High Similarity NPC249954
0.9213 High Similarity NPC96859
0.9213 High Similarity NPC305483
0.9195 High Similarity NPC185936
0.9195 High Similarity NPC233116
0.9195 High Similarity NPC168027
0.9176 High Similarity NPC475740
0.9167 High Similarity NPC470574
0.9091 High Similarity NPC472930
0.9059 High Similarity NPC474778
0.9059 High Similarity NPC474733
0.9059 High Similarity NPC145879
0.9059 High Similarity NPC118648
0.9059 High Similarity NPC31564
0.9059 High Similarity NPC474732
0.9059 High Similarity NPC222613
0.9059 High Similarity NPC475022
0.9059 High Similarity NPC28252
0.9059 High Similarity NPC94755
0.9059 High Similarity NPC55309
0.9048 High Similarity NPC85774
0.9048 High Similarity NPC214043
0.8977 High Similarity NPC272746
0.8966 High Similarity NPC309603
0.8966 High Similarity NPC186688
0.8966 High Similarity NPC473999
0.8966 High Similarity NPC1015
0.8966 High Similarity NPC31985
0.8953 High Similarity NPC159046
0.8953 High Similarity NPC233836
0.8953 High Similarity NPC187376
0.8953 High Similarity NPC58063
0.8941 High Similarity NPC469948
0.8929 High Similarity NPC278648
0.8929 High Similarity NPC476082
0.8913 High Similarity NPC316964
0.8901 High Similarity NPC43747
0.8889 High Similarity NPC173875
0.8889 High Similarity NPC174948
0.8889 High Similarity NPC200702
0.8889 High Similarity NPC318282
0.8889 High Similarity NPC469995
0.8889 High Similarity NPC255809
0.8876 High Similarity NPC475255
0.8864 High Similarity NPC126993
0.8864 High Similarity NPC85173
0.8864 High Similarity NPC48010
0.8851 High Similarity NPC242864
0.8851 High Similarity NPC53911
0.8824 High Similarity NPC221758
0.8824 High Similarity NPC59453
0.8795 High Similarity NPC164999
0.8791 High Similarity NPC328371
0.8791 High Similarity NPC192428
0.8791 High Similarity NPC95565
0.8778 High Similarity NPC111015
0.8778 High Similarity NPC245972
0.8778 High Similarity NPC196485
0.8764 High Similarity NPC475806
0.8764 High Similarity NPC473998
0.875 High Similarity NPC84271
0.875 High Similarity NPC26959
0.875 High Similarity NPC268406
0.875 High Similarity NPC102414
0.875 High Similarity NPC477943
0.875 High Similarity NPC119416
0.875 High Similarity NPC77168
0.8736 High Similarity NPC141292
0.8736 High Similarity NPC474684
0.8736 High Similarity NPC136548
0.8736 High Similarity NPC138756
0.8736 High Similarity NPC142361
0.8723 High Similarity NPC473424
0.8721 High Similarity NPC474083
0.8721 High Similarity NPC202868
0.8721 High Similarity NPC197823
0.8706 High Similarity NPC64600
0.8696 High Similarity NPC18509
0.8696 High Similarity NPC320306
0.8681 High Similarity NPC271195
0.8681 High Similarity NPC48330
0.8681 High Similarity NPC472932
0.8681 High Similarity NPC473170
0.8675 High Similarity NPC472490
0.8667 High Similarity NPC12722
0.8667 High Similarity NPC134826
0.8652 High Similarity NPC20388
0.8652 High Similarity NPC469400
0.8652 High Similarity NPC136801
0.8636 High Similarity NPC310752
0.8636 High Similarity NPC292491
0.8636 High Similarity NPC193360
0.8621 High Similarity NPC327115
0.8621 High Similarity NPC51014
0.8621 High Similarity NPC158393
0.8617 High Similarity NPC302537
0.8617 High Similarity NPC163372
0.8605 High Similarity NPC329043
0.8605 High Similarity NPC472265
0.8605 High Similarity NPC58841
0.8605 High Similarity NPC237712
0.8605 High Similarity NPC146683
0.8605 High Similarity NPC321187
0.8605 High Similarity NPC161423
0.8605 High Similarity NPC227064
0.8605 High Similarity NPC82902
0.8602 High Similarity NPC114274
0.8588 High Similarity NPC151519
0.8587 High Similarity NPC173272
0.8571 High Similarity NPC471207
0.8571 High Similarity NPC8993
0.8571 High Similarity NPC184870
0.8556 High Similarity NPC23434
0.8556 High Similarity NPC19114
0.8556 High Similarity NPC99380
0.8556 High Similarity NPC155304
0.8556 High Similarity NPC297265
0.8539 High Similarity NPC32830
0.8539 High Similarity NPC474245
0.8539 High Similarity NPC474704
0.8539 High Similarity NPC123912
0.8539 High Similarity NPC472973
0.8539 High Similarity NPC474889
0.8539 High Similarity NPC214387
0.8539 High Similarity NPC475921
0.8537 High Similarity NPC73875
0.8526 High Similarity NPC308726
0.8526 High Similarity NPC119601
0.8526 High Similarity NPC477915
0.8523 High Similarity NPC475772
0.8523 High Similarity NPC4643
0.8523 High Similarity NPC57469
0.8523 High Similarity NPC93778
0.8523 High Similarity NPC99909
0.8511 High Similarity NPC157787
0.8511 High Similarity NPC51370
0.8511 High Similarity NPC112167
0.8511 High Similarity NPC88198
0.8511 High Similarity NPC144956
0.8511 High Similarity NPC287833
0.8511 High Similarity NPC327431
0.8506 High Similarity NPC474218
0.8506 High Similarity NPC471224
0.8506 High Similarity NPC76518
0.8495 Intermediate Similarity NPC108078
0.8495 Intermediate Similarity NPC190554
0.8488 Intermediate Similarity NPC118800
0.8488 Intermediate Similarity NPC472743
0.8488 Intermediate Similarity NPC475726
0.8478 Intermediate Similarity NPC297199
0.8478 Intermediate Similarity NPC37646
0.8478 Intermediate Similarity NPC127063
0.8462 Intermediate Similarity NPC25750
0.8462 Intermediate Similarity NPC477855
0.8462 Intermediate Similarity NPC206810
0.8462 Intermediate Similarity NPC250575
0.8454 Intermediate Similarity NPC323834
0.8452 Intermediate Similarity NPC229204
0.8444 Intermediate Similarity NPC175628
0.8444 Intermediate Similarity NPC111585
0.8444 Intermediate Similarity NPC148414
0.8444 Intermediate Similarity NPC129913
0.8444 Intermediate Similarity NPC477149
0.8444 Intermediate Similarity NPC477147
0.8434 Intermediate Similarity NPC197659
0.8434 Intermediate Similarity NPC214570
0.8427 Intermediate Similarity NPC474925
0.8427 Intermediate Similarity NPC474677
0.8427 Intermediate Similarity NPC472802
0.8427 Intermediate Similarity NPC328313
0.8427 Intermediate Similarity NPC158778
0.8421 Intermediate Similarity NPC472924
0.8415 Intermediate Similarity NPC121744
0.8415 Intermediate Similarity NPC322353
0.8415 Intermediate Similarity NPC118508
0.8409 Intermediate Similarity NPC20688
0.8409 Intermediate Similarity NPC155011
0.8409 Intermediate Similarity NPC89077
0.8409 Intermediate Similarity NPC471737
0.8409 Intermediate Similarity NPC469994
0.8404 Intermediate Similarity NPC471717
0.8404 Intermediate Similarity NPC147954
0.8404 Intermediate Similarity NPC197386

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC131470 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9643 High Similarity NPD5328 Approved
0.9419 High Similarity NPD6079 Approved
0.9059 High Similarity NPD3618 Phase 1
0.8824 High Similarity NPD4786 Approved
0.8791 High Similarity NPD5220 Clinical (unspecified phase)
0.8791 High Similarity NPD5222 Approved
0.8791 High Similarity NPD5221 Approved
0.8791 High Similarity NPD4697 Phase 3
0.8696 High Similarity NPD5173 Approved
0.8696 High Similarity NPD4755 Approved
0.8667 High Similarity NPD4202 Approved
0.8621 High Similarity NPD5279 Phase 3
0.8605 High Similarity NPD3665 Phase 1
0.8605 High Similarity NPD3133 Approved
0.8605 High Similarity NPD3666 Approved
0.8588 High Similarity NPD3667 Approved
0.8511 High Similarity NPD5286 Approved
0.8511 High Similarity NPD5285 Approved
0.8511 High Similarity NPD4700 Approved
0.8511 High Similarity NPD4696 Approved
0.8421 Intermediate Similarity NPD5223 Approved
0.8333 Intermediate Similarity NPD5225 Approved
0.8333 Intermediate Similarity NPD5224 Approved
0.8333 Intermediate Similarity NPD5226 Approved
0.8333 Intermediate Similarity NPD5211 Phase 2
0.8333 Intermediate Similarity NPD4633 Approved
0.8265 Intermediate Similarity NPD7128 Approved
0.8265 Intermediate Similarity NPD6675 Approved
0.8265 Intermediate Similarity NPD6402 Approved
0.8265 Intermediate Similarity NPD5739 Approved
0.8247 Intermediate Similarity NPD4754 Approved
0.8247 Intermediate Similarity NPD5175 Approved
0.8247 Intermediate Similarity NPD5174 Approved
0.8163 Intermediate Similarity NPD5141 Approved
0.8161 Intermediate Similarity NPD4221 Approved
0.8161 Intermediate Similarity NPD4223 Phase 3
0.8152 Intermediate Similarity NPD7515 Phase 2
0.8132 Intermediate Similarity NPD4753 Phase 2
0.81 Intermediate Similarity NPD7320 Approved
0.81 Intermediate Similarity NPD6899 Approved
0.81 Intermediate Similarity NPD6881 Approved
0.809 Intermediate Similarity NPD7520 Clinical (unspecified phase)
0.809 Intermediate Similarity NPD5329 Approved
0.8081 Intermediate Similarity NPD4768 Approved
0.8081 Intermediate Similarity NPD4767 Approved
0.802 Intermediate Similarity NPD6373 Approved
0.802 Intermediate Similarity NPD6372 Approved
0.8 Intermediate Similarity NPD5690 Phase 2
0.8 Intermediate Similarity NPD5280 Approved
0.8 Intermediate Similarity NPD4694 Approved
0.8 Intermediate Similarity NPD5701 Approved
0.8 Intermediate Similarity NPD5697 Approved
0.7978 Intermediate Similarity NPD4197 Approved
0.7941 Intermediate Similarity NPD7290 Approved
0.7941 Intermediate Similarity NPD7102 Approved
0.7941 Intermediate Similarity NPD6883 Approved
0.7921 Intermediate Similarity NPD6011 Approved
0.7921 Intermediate Similarity NPD5128 Approved
0.7921 Intermediate Similarity NPD5168 Approved
0.7921 Intermediate Similarity NPD4730 Approved
0.7921 Intermediate Similarity NPD4729 Approved
0.7907 Intermediate Similarity NPD3617 Approved
0.7872 Intermediate Similarity NPD6399 Phase 3
0.7865 Intermediate Similarity NPD4788 Approved
0.7864 Intermediate Similarity NPD6650 Approved
0.7864 Intermediate Similarity NPD6401 Clinical (unspecified phase)
0.7864 Intermediate Similarity NPD8130 Phase 1
0.7864 Intermediate Similarity NPD6869 Approved
0.7864 Intermediate Similarity NPD6649 Approved
0.7864 Intermediate Similarity NPD6847 Approved
0.7864 Intermediate Similarity NPD6617 Approved
0.7843 Intermediate Similarity NPD6013 Approved
0.7843 Intermediate Similarity NPD6014 Approved
0.7843 Intermediate Similarity NPD6012 Approved
0.7802 Intermediate Similarity NPD3574 Clinical (unspecified phase)
0.7802 Intermediate Similarity NPD4689 Approved
0.7802 Intermediate Similarity NPD7521 Approved
0.7802 Intermediate Similarity NPD7334 Approved
0.7802 Intermediate Similarity NPD7146 Approved
0.7802 Intermediate Similarity NPD6684 Approved
0.7802 Intermediate Similarity NPD4693 Phase 3
0.7802 Intermediate Similarity NPD4690 Approved
0.7802 Intermediate Similarity NPD4138 Approved
0.7802 Intermediate Similarity NPD6409 Approved
0.7802 Intermediate Similarity NPD5205 Approved
0.7802 Intermediate Similarity NPD5330 Approved
0.7802 Intermediate Similarity NPD4688 Approved
0.7789 Intermediate Similarity NPD7748 Approved
0.7788 Intermediate Similarity NPD6882 Approved
0.7788 Intermediate Similarity NPD8297 Approved
0.7778 Intermediate Similarity NPD3668 Phase 3
0.7767 Intermediate Similarity NPD5248 Approved
0.7767 Intermediate Similarity NPD4634 Approved
0.7767 Intermediate Similarity NPD5169 Approved
0.7767 Intermediate Similarity NPD5251 Approved
0.7767 Intermediate Similarity NPD5247 Approved
0.7767 Intermediate Similarity NPD5134 Clinical (unspecified phase)
0.7767 Intermediate Similarity NPD5249 Phase 3
0.7767 Intermediate Similarity NPD5135 Approved
0.7767 Intermediate Similarity NPD5250 Approved
0.7765 Intermediate Similarity NPD7339 Approved
0.7765 Intermediate Similarity NPD6942 Approved
0.7732 Intermediate Similarity NPD6083 Phase 2
0.7732 Intermediate Similarity NPD6084 Phase 2
0.7727 Intermediate Similarity NPD7525 Registered
0.7708 Intermediate Similarity NPD5695 Phase 3
0.7708 Intermediate Similarity NPD5210 Approved
0.7708 Intermediate Similarity NPD4629 Approved
0.7692 Intermediate Similarity NPD5216 Approved
0.7692 Intermediate Similarity NPD5215 Approved
0.7692 Intermediate Similarity NPD5127 Approved
0.7692 Intermediate Similarity NPD5217 Approved
0.7647 Intermediate Similarity NPD5733 Approved
0.764 Intermediate Similarity NPD4139 Approved
0.764 Intermediate Similarity NPD4692 Approved
0.7634 Intermediate Similarity NPD6903 Approved
0.7634 Intermediate Similarity NPD6672 Approved
0.7634 Intermediate Similarity NPD7513 Clinical (unspecified phase)
0.7634 Intermediate Similarity NPD5737 Approved
0.7619 Intermediate Similarity NPD4808 Clinical (unspecified phase)
0.7619 Intermediate Similarity NPD4809 Clinical (unspecified phase)
0.7579 Intermediate Similarity NPD5281 Approved
0.7579 Intermediate Similarity NPD5284 Approved
0.757 Intermediate Similarity NPD6868 Approved
0.7558 Intermediate Similarity NPD3703 Phase 2
0.7551 Intermediate Similarity NPD7902 Approved
0.7547 Intermediate Similarity NPD4632 Approved
0.75 Intermediate Similarity NPD4747 Approved
0.7477 Intermediate Similarity NPD5167 Approved
0.7475 Intermediate Similarity NPD7638 Approved
0.7474 Intermediate Similarity NPD4096 Approved
0.7471 Intermediate Similarity NPD3701 Clinical (unspecified phase)
0.7442 Intermediate Similarity NPD4687 Approved
0.7431 Intermediate Similarity NPD6335 Approved
0.7416 Intermediate Similarity NPD4195 Approved
0.7412 Intermediate Similarity NPD5276 Approved
0.7407 Intermediate Similarity NPD6274 Approved
0.74 Intermediate Similarity NPD7640 Approved
0.74 Intermediate Similarity NPD7639 Approved
0.7396 Intermediate Similarity NPD8034 Phase 2
0.7396 Intermediate Similarity NPD8035 Phase 2
0.7381 Intermediate Similarity NPD3699 Clinical (unspecified phase)
0.7381 Intermediate Similarity NPD3700 Clinical (unspecified phase)
0.7381 Intermediate Similarity NPD4137 Phase 3
0.7379 Intermediate Similarity NPD6008 Approved
0.7364 Intermediate Similarity NPD7100 Approved
0.7364 Intermediate Similarity NPD7101 Approved
0.7347 Intermediate Similarity NPD6356 Clinical (unspecified phase)
0.734 Intermediate Similarity NPD3573 Approved
0.7339 Intermediate Similarity NPD6317 Approved
0.7339 Intermediate Similarity NPD6009 Approved
0.7333 Intermediate Similarity NPD4695 Discontinued
0.7333 Intermediate Similarity NPD4748 Discontinued
0.732 Intermediate Similarity NPD5133 Approved
0.73 Intermediate Similarity NPD5696 Approved
0.7297 Intermediate Similarity NPD6054 Approved
0.7297 Intermediate Similarity NPD6059 Approved
0.7294 Intermediate Similarity NPD4691 Approved
0.7273 Intermediate Similarity NPD6117 Approved
0.7273 Intermediate Similarity NPD6314 Approved
0.7273 Intermediate Similarity NPD6313 Approved
0.7263 Intermediate Similarity NPD4518 Approved
0.7245 Intermediate Similarity NPD7900 Approved
0.7245 Intermediate Similarity NPD7901 Clinical (unspecified phase)
0.7241 Intermediate Similarity NPD6113 Clinical (unspecified phase)
0.7234 Intermediate Similarity NPD4623 Approved
0.7234 Intermediate Similarity NPD4519 Discontinued
0.7232 Intermediate Similarity NPD6908 Approved
0.7232 Intermediate Similarity NPD6909 Approved
0.7222 Intermediate Similarity NPD7645 Phase 2
0.7216 Intermediate Similarity NPD6411 Approved
0.7216 Intermediate Similarity NPD6050 Approved
0.7191 Intermediate Similarity NPD6116 Phase 1
0.7188 Intermediate Similarity NPD6080 Approved
0.7188 Intermediate Similarity NPD6673 Approved
0.7188 Intermediate Similarity NPD6904 Approved
0.7182 Intermediate Similarity NPD7115 Discovery
0.7168 Intermediate Similarity NPD6370 Approved
0.7143 Intermediate Similarity NPD6319 Approved
0.7143 Intermediate Similarity NPD6412 Phase 2
0.7143 Intermediate Similarity NPD8259 Clinical (unspecified phase)
0.7129 Intermediate Similarity NPD5290 Discontinued
0.7113 Intermediate Similarity NPD5207 Approved
0.7113 Intermediate Similarity NPD5692 Phase 3
0.7111 Intermediate Similarity NPD6115 Approved
0.7111 Intermediate Similarity NPD6114 Approved
0.7111 Intermediate Similarity NPD6697 Approved
0.7111 Intermediate Similarity NPD6118 Approved
0.7108 Intermediate Similarity NPD3171 Clinical (unspecified phase)
0.7108 Intermediate Similarity NPD7341 Phase 2
0.7105 Intermediate Similarity NPD7604 Phase 2
0.7093 Intermediate Similarity NPD4244 Approved
0.7093 Intermediate Similarity NPD4245 Approved
0.7093 Intermediate Similarity NPD4789 Approved
0.7083 Intermediate Similarity NPD5208 Approved
0.708 Intermediate Similarity NPD6291 Clinical (unspecified phase)
0.708 Intermediate Similarity NPD6015 Approved
0.708 Intermediate Similarity NPD6016 Approved
0.708 Intermediate Similarity NPD5983 Phase 2
0.7071 Intermediate Similarity NPD6001 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data